A Phase I study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898

Study identifier:D7620C00001

ClinicalTrials.gov identifier:NCT03140072

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A Phase I, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Single and Multiple Ascending Oral Doses of AZD9898 in Healthy Volunteers and Asthma Patients.

Medical condition

asthma

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD9898, Matching Placebo

Sex

All

Actual Enrollment

34

Study type

Interventional

Age

18 Years - 50 Years

Date

Study Start Date: 10 May 2017
Primary Completion Date: 23 Aug 2017
Study Completion Date: 23 Aug 2017

Study design

Allocation: Randomized
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Aug 2018 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

PAREXEL

Inclusion and exclusion criteria